Publicacións nas que colabora con Jose Manuel Suárez Peñaranda (20)

2015

  1. P21Waf1/CIP1 is a poor diagnostic and prognostic marker for OSCC although its expression increases in patients with N1 regional metastasis

    Cancer Biomarkers, Vol. 15, Núm. 1, pp. 19-26

  2. The use of CA-IX as a diagnostic method for oral leukoplakia

    Biotechnic and Histochemistry, Vol. 90, Núm. 2, pp. 124-131

  3. The use of tissue microarrays for semiquantitative evaluation of ATPaseC1 expression is ineffective

    Biotechnic and Histochemistry, Vol. 90, Núm. 6, pp. 439-444

2014

  1. Expression of CA IX in dysplasia adjacent to surgical resection margins of oral squamous cell carcinoma

    Biotechnic and Histochemistry, Vol. 89, Núm. 2, pp. 91-97

  2. Quantitative determination of c-myc facilitates the assessment of prognosis of OSCC patients

    Oncology Reports, Vol. 31, Núm. 4, pp. 1677-1682

2013

  1. The role of carbonic anhydrase IX in hypoxia control in OSCC

    Journal of Oral Pathology and Medicine, Vol. 42, Núm. 1, pp. 1-8

  2. The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review)

    Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 18, Núm. 2

  3. Variable expressivity familial cherubism: Woman transmitting cherubism without suffering the disease

    Head and Face Medicine, Vol. 9, Núm. 1

2012

  1. BCL10 expression is unrelated to clinico-pathological parameters or prognoses for oral squamous cell carcinomas

    Biotechnic and Histochemistry, Vol. 87, Núm. 6, pp. 423-427

  2. Current trends in miRNAs and their relationship with oral squamous cell carcinoma

    Journal of Oral Pathology and Medicine, Vol. 41, Núm. 6, pp. 433-443

  3. Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients

    Journal of Oral Pathology and Medicine, Vol. 41, Núm. 9, pp. 667-674

  4. The role of the adenomatous polyposis coli (APC) in oral squamous cell carcinoma

    Oral Oncology, Vol. 48, Núm. 1, pp. 56-60

  5. Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - A therapeutic target?

    Cancer Letters

  6. Uma atualização na estrutura, função e regulação das V-ATPases: O papel das subunidades C

    Brazilian Journal of Biology, Vol. 72, Núm. 1, pp. 189-198

2011

  1. Hypoxia-inducible factors in OSCC

    Cancer Letters

  2. P16INK4a/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?

    Cancer Letters

  3. What real influence does the proto-oncogene c-myc have in OSCC behavior?

    Oral Oncology, Vol. 47, Núm. 8, pp. 688-692

2001

  1. Analysis of 2 antiapoptotic factors in gliomas: bcl-2 overexpression and p53 mutations

    Archives of Pathology and Laboratory Medicine, Vol. 125, Núm. 2, pp. 218-223

2000

  1. Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors

    Journal of Neurosurgical Sciences, Vol. 44, Núm. 4, pp. 203-210

1998

  1. Li-Fraumeni syndrome and osteosarcoma of the maxilla

    Journal of Oral and Maxillofacial Surgery, Vol. 56, Núm. 9, pp. 1106-1109